Cambrian Biopharma
New York · Founded 2019
About Cambrian Biopharma
Cambrian Biopharma is building the medicines that will modernize healthcare in the 21st century – therapeutics to lengthen healthspan, the period of life spent in good health. As a Distributed Development Company (or DisCo), Cambrian is advancing multiple scientific breakthroughs, each targeting a biological driver of aging. Our approach is to develop interventions that treat specific diseases first, then deploy them as preventative medicines to improve quality of life/overall quality of life as we age.
Company Facts
- Founded: 2019
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $190.8M
- Funding stage: Late Stage Venture
- Last round: Grant (Feb 2026)
- Website: cambrianbio.com
- Phone: (516) 962-3186
Industries & Categories
Biopharma, Biotechnology, Life Science
Social Profiles
Canonical: https://fsome.com/organization/cambrian-biopharma-37936 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.